ESPR Financing Cash Flow
Esperion Therapeutics Inc · Financing Cash Flow
ESPR Financing Cash Flow
Latest reported$59.90Mperiod ending
ESPR TTM Cash from Financing ($84.12M → $59.90M)
TTM financing cash flow
High-resolution chart · PNG
ESPR financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 59,900,999 | |
| 36,184,000 | |
| 41,018,000 | |
| 21,251,000 | |
| -11,622,000 | |
| 86,484,000 | |
| 55,959,000 | |
| 60,742,000 | |
| 91,574,000 | |
| 50,460,000 | |
| 15,412,000 | |
| 66,235,000 | |
| 83,534,000 | |
| 32,606,000 | |
| 276,593,000 | |
| 233,737,000 | |
| 264,742,000 | |
| 268,223,000 | |
| 225,253,000 | |
| 223,195,000 | |
| 177,756,000 | |
| 201,725,000 | |
| 38,299,000 | |
| 37,678,000 | |
| 160,540,000 | |
| 136,195,000 | |
| 129,523,000 | |
| 128,421,000 | |
| 3,070,000 | |
| 10,694,000 | |
| 10,271,000 | |
| 174,455,000 | |
| 172,901,000 | |
| 163,458,000 | |
| 163,128,000 | |
| -1,324,000 | |
| -1,345,000 | |
| -1,559,000 | |
| -1,532,000 | |
| -1,012,000 | |
| -256,000 | |
| 190,522,000 | |
| 282,803,000 | |
| 282,811,000 | |
| 287,482,000 | |
| 97,120,000 | |
| 5,049,063 | |
| 78,346,948 | |
| 89,193,340 | |
| 89,141,340 | |
| 95,029,603 | |
| 25,616,718 | |
| 9,750,688 | |
| 15,750,688 | |
| 77,437,362 | |
| 73,528,362 | |
| 73,359,000 | |
| 67,683,000 | |
| 66,000 | |
| -256,000 | |
| 1,441,000 | |
| 932,000 | |
| 23,530,000 | |
| 26,039,000 | |
| 25,016,000 | |
| 25,672,000 | |
| 60,264,000 | |
| 57,880,868 | |
| 84,118,000 |